STAT3 Dysregulation in Mature T and NK Cell Lymphomas.
Seffens A, Herrera A, Tegla C, Buus TB, Hymes KB, Ødum N, Geskin LJ, Koralov SB.
Cancers (Basel). 2019 Nov 2;11(11):1711. doi: 10.3390/cancers11111711.
PMID:31684088
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas.
Bhansali RS, Barta SK.
Cancers (Basel). 2023 Feb 1;15(3):925. doi: 10.3390/cancers15030925.
PMID:36765882
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle.
Fridman WH, Meylan M, Pupier G, Calvez A, Hernandez I, Sautès-Fridman C.
Immunity. 2023 Oct 10;56(10):2254-2269. doi: 10.1016/j.immuni.2023.08.009. Epub 2023 Sep 11.
PMID:37699391
Mature B, T and NK-cell, plasma cell and histiocytic/dendritic cell neoplasms: classification according to the World Health Organization and International Consensus Classification.
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Bachy E, Savage KJ, Huang H, Kwong YL, Gritti G, Zhang Q, Liberati AM, Cao J, Yang H, Hao S, Hu J, Zhou K, Petrini M, Russo F, Zhang H, Sang W, Ji J, Ferreri AJM, Damaj GL, Liu H, Zhang W, Ke X, Ghiggi C, Huang S, Li X, Yao H, Paik J, Novotny W, Zhou W, Zhu H, Zinzani PL.
Blood Adv. 2023 Aug 22;7(16):4435-4447. doi: 10.1182/bloodadvances.2022009575.
PMID:37276067
Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents.